This company seems to have been delisted
Reason: Merged with Ayala Pharmaceuticals
Source: https://ir.ayalapharma.com/news-releases/news-release-details/advaxis-and-ayala-pharmaceuticals-complete-merger
Reason: Merged with Ayala Pharmaceuticals
Source: https://ir.ayalapharma.com/news-releases/news-release-details/advaxis-and-ayala-pharmaceuticals-complete-merger
Advaxis
ADXS
0,02778 €
Share price
0.00%
Change (1 day)
-94.91%
Change (1 year)
Categories
Advaxis (ADXS) - Total assets
Total assets on the balance sheet as of December 2023 : €15.35 Million
According to Advaxis's latest financial reports the company's total assets are €15.35 Million. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Advaxis - Total assets on balance sheet (from 2019 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2023-12-31 | €14.99 M | 107.07% |
| 2022-12-31 | €7.24 M | -80.06% |
| 2021-12-31 | €36.31 M | -2.53% |
| 2020-12-31 | €37.25 M | 108.13% |
| 2019-12-31 | €17.9 M | -24.5% |
| 2018-12-31 | €23.71 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 | €0.10 B | 582.77% | 🇺🇸 USA |
 | €35.91 M | 133.96% | 🇺🇸 USA |
 | €0.54 B | 3,475.09% | 🇺🇸 USA |